In the present study, a rat HCC model is employed to determine the changes in mRNA levels of VEGF and VEGFR, and the expression of the K-ras protein when curcumin is administered together with a biological target, in order to provide experimental evidence for design comprehensive therapy and improve clinical outcomes. This evidence concerns the gene VEGFA and hepatocellular carcinoma.